IO-202 as Monotherapy and IO-202 Plus Azacitidine ± Venetoclax in Patients in AML and CMML
Clinical trial NCT04372433 · COMPLETED
Trial details
- NCT number
- NCT04372433
- Sponsor
- Immune-Onc Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-14
- Primary completion
- 2025-01-31
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.